ALDH3A2 |
aldehyde dehydrogenase 3 family member A2 |
|
|
|
CFAP410 |
cilia and flagella associated protein 410 |
|
|
|
COL2A1 |
collagen type II alpha 1 chain |
- Collagen degradation
- Collagen degradation
- Extracellular matrix organization
- Collagen biosynthesis and modifying enzymes
- Signaling by PDGF
- Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
- Assembly of collagen fibrils and other multimeric structures
- Integrin cell surface interactions
- Integrin cell surface interactions
- Non-integrin membrane-ECM interactions
- ECM proteoglycans
- ECM proteoglycans
- NCAM1 interactions
- MET activates PTK2 signaling
- Collagen chain trimerization
|
- Collagenase clostridium histolyticum
|
- Type II collagenopathies, including: Achondrogenesis II; Hypochondrogenesis; SED congenita; SMED Strudwick type; Kniest dysplasia; Spondyloperipheral dysplasia; Osteoarthritis with mild chondrodysplasia; Stickler syndrome 1; Platyspondylic skeletal dysplasia, Torrance type; Epiphyseal dysplasia, multiple, with myopia and deafness; Czech dysplasia
- Vitreoretinal degeneration, including: Stickler syndrome type I (STL1); Stickler syndrome type II (STL2); Snowflake vitreoretinal degeneration (SVD); Wagner syndrome 1 (WGN1); Knobloch syndrome (KNO); Enhanced S-cone syndrome (ESCS); Autosomal dominant vitreoretinochoroidopathy (ADVIRC)
- Osteoarthritis with mild chondrodysplasia
|
COL6A2 |
collagen type VI alpha 2 chain |
- Collagen degradation
- Collagen biosynthesis and modifying enzymes
- Signaling by PDGF
- Assembly of collagen fibrils and other multimeric structures
- Integrin cell surface interactions
- ECM proteoglycans
- ECM proteoglycans
- NCAM1 interactions
- Collagen chain trimerization
|
|
- Congenital muscular dystrophies (CMD/MDC), including: Merosin-deficient CMD (MDC1A); Ullrich CMD (UCMD); Integrin alpha7-deficient CMD; CMD with joint hyperlaxity (CMDH); CMD with epidermolysis bullosa; Walker-Warburg syndrome (WWS); Muscle-eye-brain disease (MEB); Fukuyama CMD (FCMD); CMD with muscle hypertrophy (MDC1C); CMD with severe intellectual impairment and abnormal glycosylation (MDC1D); Rigid spine syndrome (RSS); LMNA-deficient CMD; CMD with respiratory failure and muscle hypertrophy (MDC1B); Bethlem myopathy
|
CSTB |
cystatin B |
|
|
- Progressive myoclonic epilepsy (PME), including: Lafora disease (LBD); Unverricht-Lundborg disease (ULD); Neuronal ceroid lipofuscinoses (NCL); Type I sialidosis; Action myoclonus-renal failure syndrome (AMRF); Type III Gaucher disease (GD)
|
DCN |
decorin |
- Degradation of the extracellular matrix
- A tetrasaccharide linker sequence is required for GAG synthesis
- Chondroitin sulfate biosynthesis
- Dermatan sulfate biosynthesis
- CS/DS degradation
- ECM proteoglycans
- ECM proteoglycans
- Defective B4GALT7 causes EDS, progeroid type
- Defective B3GAT3 causes JDSSDHD
- Defective CHST3 causes SEDCJD
- Defective CHST14 causes EDS, musculocontractural type
- Defective CHSY1 causes TPBS
- Defective B3GALT6 causes EDSP2 and SEMDJL1
|
|
- Congenital stromal corneal dystrophy (CSCD); Congenital hereditary stromal dystrophy; Witschel dystrophy
|
DNAJB11 |
DnaJ heat shock protein family (Hsp40) member B11 |
- XBP1(S) activates chaperone genes
|
|
|
FAM3B |
FAM3 metabolism regulating signaling molecule B |
|
|
|
FGF7 |
fibroblast growth factor 7 |
- PI3K Cascade
- PIP3 activates AKT signaling
- FGFR2b ligand binding and activation
- Activated point mutants of FGFR2
- Constitutive Signaling by Aberrant PI3K in Cancer
- Phospholipase C-mediated cascade; FGFR2
- PI-3K cascade:FGFR2
- SHC-mediated cascade:FGFR2
- FRS-mediated FGFR2 signaling
- Negative regulation of FGFR2 signaling
- Signaling by FGFR2 in disease
- RAF/MAP kinase cascade
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
|
|
|
HCFC2 |
host cell factor C2 |
|
|
|
LAMB1 |
laminin subunit beta 1 |
- Degradation of the extracellular matrix
- Laminin interactions
- Laminin interactions
- Non-integrin membrane-ECM interactions
- ECM proteoglycans
- L1CAM interactions
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- MET activates PTK2 signaling
- Post-translational protein phosphorylation
- EGR2 and SOX10-mediated initiation of Schwann cell myelination
|
|
|
LCMT2 |
leucine carboxyl methyltransferase 2 |
- Synthesis of wybutosine at G37 of tRNA(Phe)
- Synthesis of wybutosine at G37 of tRNA(Phe)
|
|
|
LGALS3BP |
galectin 3 binding protein |
|
|
|
MAG |
myelin associated glycoprotein |
- Axonal growth inhibition (RHOA activation)
- Basigin interactions
- EGR2 and SOX10-mediated initiation of Schwann cell myelination
|
|
|
MLLT3 |
MLLT3 super elongation complex subunit |
- Formation of RNA Pol II elongation complex
- RNA Polymerase II Pre-transcription Events
- RNA Polymerase II Transcription Elongation
|
|
|
MPRIP |
myosin phosphatase Rho interacting protein |
- Signaling by BRAF and RAF fusions
|
|
|
MTDH |
metadherin |
|
|
|
PCNT |
pericentrin |
- Regulation of PLK1 Activity at G2/M Transition
- Loss of Nlp from mitotic centrosomes
- Recruitment of mitotic centrosome proteins and complexes
- Loss of proteins required for interphase microtubule organization from the centrosome
- Recruitment of NuMA to mitotic centrosomes
- Anchoring of the basal body to the plasma membrane
- AURKA Activation by TPX2
- Chaperone Mediated Autophagy
- Late endosomal microautophagy
- Aggrephagy
- Aggrephagy
|
|
- Microcephalic osteodysplastic primordial dwarfism, type II (MOPD II)
- Seckel syndrome
|
PDGFA |
platelet derived growth factor subunit A |
- Non-integrin membrane-ECM interactions
|
|
- Malignant pleural mesothelioma
- Glioma
|
PDGFB |
platelet derived growth factor subunit B |
- Platelet degranulation
- PIP3 activates AKT signaling
- Downstream signal transduction
- Signaling by PDGF
- Constitutive Signaling by Aberrant PI3K in Cancer
- Non-integrin membrane-ECM interactions
- RAF/MAP kinase cascade
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
|
|
- Malignant pleural mesothelioma
- Glioma
|
PDK1 |
pyruvate dehydrogenase kinase 1 |
- Regulation of pyruvate dehydrogenase (PDH) complex
- Signaling by Retinoic Acid
|
- 4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE
- Dichloroacetic Acid
|
|
PEX26 |
peroxisomal biogenesis factor 26 |
- Peroxisomal protein import
- Peroxisomal protein import
- Class I peroxisomal membrane protein import
|
|
- Zellweger syndrome spectrum, including: Zellweger syndrome (ZS); Adrenoleukodystrophy, neonatal (NALD); Infantile Refsum disease (IRD)
|
PIGS |
phosphatidylinositol glycan anchor biosynthesis class S |
- Attachment of GPI anchor to uPAR
|
|
|
RUNX1 |
RUNX family transcription factor 1 |
- Pre-NOTCH Transcription and Translation
- Organic cation transport
- RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
- RUNX1 regulates estrogen receptor mediated transcription
- Regulation of RUNX1 Expression and Activity
- Regulation of RUNX1 Expression and Activity
- RUNX1 regulates expression of components of tight junctions
- RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
- RUNX1 regulates transcription of genes involved in differentiation of HSCs
- RUNX1 regulates transcription of genes involved in differentiation of HSCs
- RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
- RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
- RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
- RUNX1 regulates transcription of genes involved in BCR signaling
- RUNX1 regulates transcription of genes involved in differentiation of myeloid cells
- RUNX1 regulates transcription of genes involved in interleukin signaling
- RUNX1 regulates transcription of genes involved in WNT signaling
- RUNX2 regulates genes involved in differentiation of myeloid cells
- RUNX3 regulates p14-ARF
- Estrogen-dependent gene expression
- Transcriptional regulation of granulopoiesis
|
|
- Chronic myeloid leukemia (CML)
- Thrombocytopenia (THC); Familial platelet disorder with associated myeloid malignancy (FPDMM)
- Acute myeloid leukemia (AML)
- Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
|